PRESS RELEASE published on 07/08/2024 at 07:56, 1 year 6 months ago AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19 AB Science annonce des résultats positifs de son étude de phase 2 évaluant le masitinib dans la COVID-19. Les analyses montrent un potentiel traitement prometteur pour les patients hospitalisés COVID-19 Traitement Étude De Phase 2 AB Science Masitinib
BRIEF published on 06/28/2024 at 12:36, 1 year 7 months ago AB Science fait le point sur la demande d'autorisation du masitinib dans la SLA Autorisation De Mise Sur Le Marché AB Science Masitinib EMA SLA
BRIEF published on 06/28/2024 at 12:36, 1 year 7 months ago AB Science provides an update on the application for authorization of masitinib in ALS ALS AB Science Masitinib EMA Marketing Authorization
PRESS RELEASE published on 06/28/2024 at 12:31, 1 year 7 months ago AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA AB Science annonce un avis négatif sur la demande de mise sur le marché du masitinib dans la SLA et prévoit un réexamen du dossier. Détails sur les raisons et les prochaines étapes AB Science Masitinib Sclérose Latérale Amyotrophique Autorisation Conditionnelle Réexamen Dossier
PRESS RELEASE published on 06/28/2024 at 12:31, 1 year 7 months ago AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS AB Science receives negative opinion from CHMP on masitinib's conditional marketing authorization for ALS treatment but plans re-examination due to urgent patient need and safety considerations AB Science Masitinib CHMP ALS Treatment Conditional Marketing Authorization
BRIEF published on 06/27/2024 at 10:20, 1 year 7 months ago AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024 Actionnaires Capital Social Assemblée Générale Resolutions AB Science
BRIEF published on 06/27/2024 at 10:20, 1 year 7 months ago AB Science - Results of the Combined General Meeting of June 26, 2024 Shareholders Share Capital Resolutions General Assembly AB Science
PRESS RELEASE published on 06/27/2024 at 10:15, 1 year 7 months ago AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024 Assemblée Générale Mixte de AB Science du 26 juin 2024 : toutes les résolutions ordinaires et extraordinaires adoptées sauf une. Actionnariat présent : 21.948.183 actions ordinaires et 38.495.615 droits de vote Actionnaires Droits De Vote Assemblée Générale Resolutions AB Science
BRIEF published on 05/17/2024 at 18:03, 1 year 8 months ago Correction des Comptes Consolidés de AB Science pour 2023 Résultats Financiers Recherche Et Développement Comptes Consolidés AB Science Correction Comptable
BRIEF published on 05/17/2024 at 18:03, 1 year 8 months ago Correction of the Consolidated Accounts of AB Science for 2023 Financial Results Research And Development Consolidated Accounts AB Science Accounting Correction
Published on 02/02/2026 at 23:55, 2 hours 23 minutes ago 2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 2 hours 23 minutes ago 55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 2 hours 53 minutes ago Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 4 hours 13 minutes ago Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 11 hours 18 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 20:00, 6 hours 17 minutes ago CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 6 hours 20 minutes ago US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 6 hours 35 minutes ago EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 7 hours 12 minutes ago Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 19:00, 7 hours 18 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 02/02/2026 at 18:23, 7 hours 54 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 7 hours 54 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 8 hours 18 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 8 hours 18 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 8 hours 18 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social